Chad Straughan, PharmD

Pharmacy

Chad Straughan, PharmD

Chad Straughan, PharmD has over 20 years experience in the pharmaceutical and retail pharmacy industry focusing on the development and management of patient access and procurement of medicine and specialty products in various disease states.

He began his career with Eli Lilly, after graduating from pharmacy school, in the diabetes marketplace relaunching Humalog and launching numerous first to market products, including Byetta, Cialis, Actos, Cymbalta, Effient, and Livalo. He transitioned his career from sales to training, developing national training programs specializing in customer service and customer relationships. He then moved onto management and into the hospital account space developing programs focusing on access to C suite executives. In 2012, he entered the startup medical device space as medical director. He developed the sales strategy and implementation plan, creating the sales force initiatives, the hiring of the sales force, and preparing them for the launch of a one a kind medical device product in the drug diversion space. He also worked closely with the DEA to ensure compliance and synergy existed to help reduce drug diversion in the healthcare space.

Getting back to his roots, most recently, he has been the owner and pharmacist in charge of a large independent retail pharmacy he established in 2014. He developed and implemented a business plan that focused on diversifying the pharmacy retail space and leveraging pharmaceutical market access and patient services to grow the pharmacy business into a highly successful and sought after retail pharmacy, partnering in the pharmaceutical manufacturer space covering South Carolina and Georgia.

He also serves as an expert pharmacist, advising law firms representing local and national clients on malpractice cases.

Chad completed his undergraduate and earned his Doctorate of Pharmacy from the University of North Carolina at Chapel Hill. He currently resides in Mount Pleasant, SC with his 4 children.